Straits Times Index
3,300.00 -4.00 (-0.12%) S&P 500
5,494.88 +7.85 (+0.14%) Dow
38,915.94 +81.08 (+0.21%) Nasdaq
17,874.67 +12.43 (+0.07%) Bitcoin USD
64,943.79 -78.21 (-0.12%) CMC Crypto 200
1,348.95 -33.71 (-2.44%)
Danaher Corporation (0R2B.L)
| Previous close | 257.51 |
| Open | 253.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 248.12 - 257.44 |
| 52-week range | 182.16 - 269.23 |
| Volume | |
| Avg. volume | 37,092 |
| Market cap | 179.442B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 0.29 |
| EPS (TTM) | 8.64 |
| Earnings date | 23 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireDanaher appoints Julie Sawyer Montgomery to Executive Vice President for Diagnostics
Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a leading global life sciences and diagnostics innovator, today announced that Julie Sawyer Montgomery will succeed Joakim Weidemanis as Executive Vice President, Diagnostics effective as of July 1, 2024. Mr. Weidemanis will support the transition over the next three months and will retire from Danaher on September 30, 2024 after 13 years of service.
Insider MonkeyRGIA: “Danaher Corporation (DHR): Purity in the Crown Jewel of Bioprocessing”
RGA Investment Advisors, an investment management company released its first quarter 2024 investor letter. A copy of the letter can be downloaded here. Strong economic growth combined with frustratingly resilient inflation defined the macroeconomic environment in the first quarter. The large caps outperformed their smaller counterparts in Q1. It may be the result of continued […]
ZacksHere's Why Hold Strategy Is Apt for Danaher (DHR) Stock Now
Strength in the Life Sciences segment augurs well for Danaher (DHR). The company's measures to reward its shareholders are promising.
